212 related articles for article (PubMed ID: 21871300)
1. Previous head and neck cancers portend poor prognoses in lung cancer patients.
Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
[TBL] [Abstract][Full Text] [Related]
2. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy?
Lee P; de Bree R; Brokx HA; Leemans CR; Postmus PE; Sutedja TG
Lung Cancer; 2008 Dec; 62(3):309-15. PubMed ID: 18486989
[TBL] [Abstract][Full Text] [Related]
3. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
4. Analysis of second primary lung cancers in the SEER database.
Bhaskarla A; Tang PC; Mashtare T; Nwogu CE; Demmy TL; Adjei AA; Reid ME; Yendamuri S
J Surg Res; 2010 Jul; 162(1):1-6. PubMed ID: 20400118
[TBL] [Abstract][Full Text] [Related]
5. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
Milano MT; Zhang H
Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
[TBL] [Abstract][Full Text] [Related]
6. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Rusthoven KE; Flaig TW; Raben D; Kavanagh BD
Clin Lung Cancer; 2008 Mar; 9(2):106-11. PubMed ID: 18501097
[TBL] [Abstract][Full Text] [Related]
7. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.
Atienza JA; Dasanu CA
Curr Med Res Opin; 2012 Dec; 28(12):1899-909. PubMed ID: 23121148
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients.
Herrera LJ; Correa AM; Vaporciyan AA; Hofstetter WL; Rice DC; Swisher SG; Walsh GL; Roth JA; Mehran RJ
Ann Thorac Surg; 2006 Dec; 82(6):1982-7; discussion 1987-8. PubMed ID: 17126095
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
10. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
[TBL] [Abstract][Full Text] [Related]
11. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
12. A population-based study of therapy and survival for patients with head and neck cancer treated in the community.
Dansky Ullmann C; Harlan LC; Shavers VL; Stevens JL
Cancer; 2012 Sep; 118(18):4452-61. PubMed ID: 22252676
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
[TBL] [Abstract][Full Text] [Related]
14. TNM stage is the most important determinant of survival in metachronous lung cancer.
Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
16. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
Rusthoven K; Chen C; Raben D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
[TBL] [Abstract][Full Text] [Related]
17. Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis.
Rose Ragin CC; Taioli E
Head Neck; 2008 Jan; 30(1):58-66. PubMed ID: 17657793
[TBL] [Abstract][Full Text] [Related]
18. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
19. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
Budnik J; DeNunzio NJ; Singh DP; Milano MT
Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
